Sheel Bio.

Which are the latest news on Sheel Bio.?

Why is Sheel Biotech Ltd falling/rising?

As of 05-Sep, Sheel Biotech Ltd's stock price is at 61.60, down 4.5% and underperforming its sector by 13.28%. Despite a recent increase in investor participation, the stock has declined 10.07% over the month, indicating mixed performance trends.

As of 05-Sep, Sheel Biotech Ltd's stock price is falling, currently at 61.60, reflecting a change of -2.9, or -4.5%. This decline is evident as the stock has underperformed its sector by 13.28% today. Over the past week, the stock has shown a positive return of 4.85%, contrasting with the Sensex's decline of 1.15%. However, on a monthly basis, the stock has decreased by 10.07%, while the Sensex has only fallen by 2.91%. <BR><BR>Despite the current price drop, there are indications of rising investor participation, with a delivery volume increase of 47.06% against the 5-day average noted on September 3rd. Additionally, the stock is trading higher than its 5-day and 100-day moving averages, but lower than its 20-day, 50-day, and 200-day moving averages, suggesting mixed performance trends. Overall, the combination of recent price declines, underperformance relative to the sector, and the significant monthly drop contributes to the current falling stock price of Sheel Biotech Ltd.

What does Sheel Bio. do?

Sheel Biotech Ltd operates in the Other Agricultural Products industry as a Micro Cap company with a market cap of INR 120 Cr. Key metrics include a P/E ratio of 11.00, a debt-equity ratio of 0.32, and a return on equity of 13.99%.

Overview: <BR>Sheel Biotech Ltd operates in the Other Agricultural Products industry and is classified as a Micro Cap company.<BR><BR>History: <BR>The incorporation year and any status changes are not available. The latest quarter for which sales and profit are reported is also not available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 120 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 11.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.32 <BR>Return on Equity: 13.99% <BR>Price-to-Book: 1.42<BR><BR>Contact Details: <BR>Registrar Address: Not available <BR>Phone: Not available <BR>Email: Not available <BR>Website: Not available

Who are the peers of the Sheel Bio.?

Sheel Bio.'s peers include Kohinoor Foods, Shreeoswal Seeds, Upsurge Seeds, Puretrop Fruits, Nag. Agri Tech., JK Agri Genetics, Naturite Agro, Harshdeep Horti., and MANGALAM SEEDS. Kohinoor Foods has the highest 1-year return at -0.26%, while Upsurge Seeds has the lowest at -48.07%.

Peers: The peers of Sheel Bio. are Kohinoor Foods, Shreeoswal Seeds, Upsurge Seeds, Puretrop Fruits, Nag. Agri Tech., JK Agri Genetics, Naturite Agro, Harshdeep Horti., and MANGALAM SEEDS.<BR><BR>Quality Snapshot: Excellent management risk is observed at Harshdeep Horti., while Average management risk is found at JK Agri Genetics and MANGALAM SEEDS, and the rest have Below Average management risk. Good growth is noted at Shreeoswal Seeds, Upsurge Seeds, Nag. Agri Tech., Harshdeep Horti., and MANGALAM SEEDS, while the rest have Below Average growth. Good capital structure is seen at Puretrop Fruits and Nag. Agri Tech., Average capital structure is found at MANGALAM SEEDS and JK Agri Genetics, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Kohinoor Foods at -0.26%, while Upsurge Seeds has the lowest at -48.07%. Sheel Bio.'s 1-year return is not available for comparison. Additionally, peers with negative six-month returns include Upsurge Seeds and Shreeoswal Seeds.

How big is Sheel Bio.?

As of 31st August, Sheel Biotech Ltd has a market capitalization of 120.00 Cr, classified as a Micro Cap, with no valid financial data available for Net Sales and Net Profit for the latest four quarters. The balance sheet as of March 2025 shows Shareholder's Funds of 83.85 Cr and Total Assets of 113.23 Cr.

As of 31st August, <BR><BR>Market Cap: Sheel Biotech Ltd has a market capitalization of 120.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 83.85 Cr and Total Assets totaling 113.23 Cr.